Granulocyte colony-stimulating factor use during first urse chemotherapy for non-Hodgkin's lymphoma: National SEER-medicare study.

被引：0
|
作者：
Chrischilles, EA
Rubenstein, LM
Voelker, MD
Wright, KB
Link, BK
Brooks, JM
Delgado, DJ
机构：
[1] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA
[2] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA
[3] Univ Iowa, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA
[4] Amgen Inc, Thousand Oaks, CA USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1817
引用
收藏
页码：499A / 499A
页数：1
相关论文
共 50 条
  • [31] Low-dose Granulocyte Colony-Stimulating Factor Overcomes Neutropenia in the Treatment of Non-Hodgkin’s Lymphoma with Higher Cost-Effectiveness
    Takeshi Hara
    Hisashi Tsurumi
    Senji Kasahara
    Nobuhiro Kanemura
    Takeshi Yoshikawa
    Naoe Goto
    Yasushi Kojima
    Toshiki Yamada
    Michio Sawada
    Takeshi Takahashi
    Masami Oyama
    Eiichi Tomita
    Hisataka Moriwaki
    International Journal of Hematology, 2005, 82 : 430 - 436
  • [32] Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: Factors influencing chemotherapy administration
    Gisselbrecht, C
    Haioun, C
    Lepage, E
    Bastion, Y
    Tilly, H
    Bosly, A
    Dupriez, B
    Marit, G
    Herbrecht, R
    Deconinck, E
    Marolleau, JP
    Yver, A
    DabouzHarrouche, F
    Coiffier, B
    Reyes, F
    LEUKEMIA & LYMPHOMA, 1997, 25 (3-4) : 289 - 300
  • [33] Low-dose granulocyte colony-stimulating factor overcomes neutropenia in in the treatment of non-Hodgkin's lymphoma with higher cost-effectiveness
    Hara, T
    Tsurumi, H
    Kasahara, S
    Kanemura, N
    Yoshikawa, T
    Goto, N
    Kojima, Y
    Yamada, T
    Sawada, M
    Takahashi, T
    Oyama, M
    Tomita, E
    Moriwaki, H
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 82 (05) : 430 - 436
  • [34] EFFECT OF GRANULOCYTE COLONY-STIMULATING FACTOR ON NEUTROPENIA DUE TO CHEMOTHERAPY FOR NON-HODGKINS-LYMPHOMA
    YOSHIDA, T
    NAKAMURA, S
    OHTAKE, S
    OKAFUJI, K
    KOBAYASHI, K
    KONDO, K
    KANNO, M
    MATANO, S
    MATSUDA, T
    KANAI, M
    SUGIMOTO, R
    OGAWA, M
    TAKAKU, F
    CANCER, 1990, 66 (09) : 1904 - 1909
  • [35] Increased risk of myelotoxicity in elderly patients with non-hodgkin lymphoma - The case for routine prophylaxis with colony-stimulating factor beginning in the first cycle of chemotherapy
    Balducci, L
    Repetto, L
    CANCER, 2004, 100 (01) : 6 - 11
  • [36] Granulocyte Colony-Stimulating Factor (GCSF) Use with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone plus /- Rituximab ( CHOP±R) Treatment for Aggressive Non-Hodgkin's Lymphoma (aNHL)
    Kouroukis, Tom
    Cheung, Winson Y.
    Abdel-Samad, Nizar
    Sehdev, Sandeep
    Poulin-Costello, Melanie
    Gillesby, Brad
    Robson, Ewan J. D.
    BLOOD, 2016, 128 (22)
  • [37] A clinicopathological study of Hodgkin's disease producing granulocyte colony-stimulating factor - The first case reported in the world
    Kaito, H
    Kuraishi, Y
    Usui, N
    Kobayashi, T
    Yamazaki, H
    Nakamura, T
    Takasaki, N
    Tada, N
    Ogiwara, A
    Fujii, T
    Unozawa, T
    Yamaguchi, K
    Nagamine, M
    Nikaidoo, T
    Takagi, K
    BLOOD, 1995, 86 (10) : 3251 - 3251
  • [38] A double-blind low dose-finding phase II study of granulocyte colony-stimulating factor combined with chemotherapy for stem cell mobilization in patients with non-Hodgkin's lymphoma
    Lefrere, Francois
    Zohar, Sarah
    Bresson, Jean-Louis
    Chevret, Sylvie
    Mogenet, Agnes
    Audat, Francoise
    Durand-Zaleski, Isabelle
    Ghez, David
    Dal Cortivo, Liliane
    Piesvaux, Patrick
    Cavazzana-Calvo, Marina
    Varet, Bruno
    HAEMATOLOGICA, 2006, 91 (04) : 550 - 553
  • [39] High-dose intensity cyclophosphamide, epidoxorubicin, vincristine and prednisone by shortened intervals and granulocyte colony-stimulating factor in non-Hodgkin's lymphoma: a phase II study
    P Pronzato
    R Lionetto
    F Botto
    F Pensa
    A Tognoni
    British Journal of Cancer, 1998, 78 : 777 - 780
  • [40] Efficacy of delayed granulocyte colony-stimulating factor after full dose CHOP therapy in non-Hodgkin's lymphoma: A pilot study for a leukocyte count oriented regimen
    Sawada, KI
    Sato, N
    Kohno, M
    Hannda, H
    Yasukouchi, T
    Tanngo, M
    Hirayama, A
    Koike, T
    LEUKEMIA & LYMPHOMA, 1995, 20 (1-2) : 103 - 109
12345